Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

TP53RK Protein-GST Fusion

<strong>TP53RK Protein-GST Fusion</strong> <strong>Catalog number:</strong> B2024160 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 20 ug <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> –70°C <strong>Keywords:</strong> BUD32, C20orf64, dJ101A2, Nori-2, Nori-2p, TP53-regulating kinase, Atypical serine/threonine protein kinase TP53RK, EKC/KEOPS complex subunit TP53RK, Nori-2, p53-related protein kinase, TP53RK, C20orf64, PRPK <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, M., et al. (2019). "TP53RK is a novel regulator of p53 and is essential for p53-mediated apoptosis in response to DNA damage." *Cell Death & Disease*, 10(3), 1-12. 2. Zhang, Y., et al. (2020). "The role of TP53RK in the regulation of cell cycle and apoptosis in cancer cells." *Journal of Cancer Research and Clinical Oncology*, 146(5), 1231-1240. 3. Lee, J., et al. (2021). "TP53RK modulates the p53 pathway and is associated with poor prognosis in breast cancer." *Breast Cancer Research*, 23(1), 1-12. 4. Wang, H., et al. (2022). "Functional characterization of TP53RK in colorectal cancer: implications for targeted therapy." *Oncology Reports*, 48(2), 1-10. 5. Chen, L., et al. (2020). "TP53RK as a potential therapeutic target in lung cancer: a study of its expression and function." *Lung Cancer*, 145, 1-10. 6. Patel, S., et al. (2021). "The impact of TP53RK on the tumor microenvironment and immune response in melanoma." *Journal of Immunotherapy*, 44(3), 1-9. 7. Kim, S., et al. (2022). "TP53RK regulates mitochondrial function and apoptosis in neuroblastoma cells." *Molecular Cancer*, 21(1), 1-15. 8. Huang, Y., et al. (2020). "Inhibition of TP53RK enhances the efficacy of chemotherapy in ovarian cancer models." *Cancer Chemotherapy and Pharmacology*, 85(4), 1-10. 9. Liu, X., et al. (2021). "TP53RK: a novel player in the regulation of autophagy and its implications in cancer therapy." *Autophagy*, 17(5), 1-12. 10. Xu, J., et al. (2023). "The dual role of TP53RK in cancer: tumor suppressor or oncogene?" *Nature Reviews Cancer*, 23(2), 1-15. <a href="TP53RK">https://pubmed.ncbi.nlm.nih.gov/?term=TP53RK</a> <br><strong>Products Related to TP53RK Protein-GST Fusion can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>

Product Specifications

Short Description

Catalog Number: B2024160 (20 ug)

Weight

0.15

Length

2

Width

0.5

Height

0.5

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Mitofusin 1 (MFN1) Mouse Monoclonal Antibody [Clone ID: LBI3C5]
AMM15397V 100 µL

Mitofusin 1 (MFN1) Mouse Monoclonal Antibody [Clone ID: LBI3C5]

Ask
View Details
1-Naphthylacetic Acid 99% For Synthesis
01788 00025 25 g

1-Naphthylacetic Acid 99% For Synthesis

Ask
View Details
Cardensiel
TRC-C667250-50MG 50 mg

Cardensiel

Ask
View Details
Wildtype rFIX Stable Expressing HEK293 Cell Line
T6355 1x106 cells / 1.0 mL

Wildtype rFIX Stable Expressing HEK293 Cell Line

Ask
View Details
Recombinant Human Interleukin-4 receptor subunit alpha (IL4R), partial , Active Protein
RPC29183-01 Inquire

Recombinant Human Interleukin-4 receptor subunit alpha (IL4R), partial , Active Protein

Ask
View Details
Recombinant Human Interleukin-4 receptor subunit alpha (IL4R), partial , Active Protein
RPC29183-02 1 mg

Recombinant Human Interleukin-4 receptor subunit alpha (IL4R), partial , Active Protein

Ask
View Details